Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

NCT02090933 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

No Evidence of Disease

Interventions

DRUG: Celecoxib
OTHER: Laboratory Biomarker Analysis
PROCEDURE: UV Light Therapy

Sponsor

National Cancer Institute (NCI)